Zarrindast Mohammad-Reza, Ebrahimi-Ghiri Mohaddeseh, Rostami Parvin, Rezayof Ameneh
Department of Pharmacology and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Behav Brain Res. 2007 Jul 19;181(1):35-41. doi: 10.1016/j.bbr.2007.03.019. Epub 2007 Mar 19.
In the present study, the effect of repeated administration of morphine into the ventral pallidum (intra-VP) on the conditioned place preference (CPP) induced by systemic morphine injection was investigated in male Wistar rats. Subcutaneous (s.c.) administration of morphine (2.5, 5 and 7.5mg/kg), during conditioning, induced conditioned place preference (CPP). The maximum response was obtained with 5mg/kg of morphine. Lower dose of morphine (0.5mg/kg) did not induce CPP, but in the animals which had previously, received 3 days intra-VP repeated injections of morphine (3 or 5microg/rat) followed by 5 days free of the drug, elicited a significant CPP. Moreover, 3 days intraperitoneal (i.p.) pretreatment with different doses of naloxone (0.5, 1 and 2mg/kg), SCH 23390 (0.012, 0.025 and 0.05mg/kg) or sulpiride (6.2, 12.5 and 25mg/kg) in combination with repeated injections of morphine (5microg/rat), blocked the opioid response on the acquisition of morphine (0.5mg/kg) CPP. On the other hand, our results showed that 3 days single repeated administration of different doses of naloxone (0.5, 1 or 2mg/kg, i.p.), SCH 23390 but not sulpiride followed by 5 days free of the drug, significantly decreased the acquisition of morphine (0.5mg/kg) CPP and also induced place aversion. Furthermore, the drugs' injections had no effect on locomotor activity on the testing phase of CPP. It is concluded that repeated intra-VP injections of morphine induces behavioral sensitization, which may be due to the opioidrgic and/or dopaminergic mechanism(s).
在本研究中,我们在雄性Wistar大鼠中研究了向腹侧苍白球(脑室内注射)重复注射吗啡对全身注射吗啡诱导的条件性位置偏爱(CPP)的影响。在条件训练期间,皮下注射吗啡(2.5、5和7.5mg/kg)可诱导条件性位置偏爱(CPP)。5mg/kg的吗啡可获得最大反应。较低剂量的吗啡(0.5mg/kg)不会诱导CPP,但在先前接受过3天脑室内重复注射吗啡(3或5μg/只大鼠)且随后5天未用药的动物中,可引发显著的CPP。此外,用不同剂量的纳洛酮(0.5、1和2mg/kg)、SCH 23390(0.012、0.025和- 0.05mg/kg)或舒必利(6.2、12.5和25mg/kg)进行3天腹腔内预处理,并联合重复注射吗啡(5μg/只大鼠),可阻断阿片类药物对吗啡(0.5mg/kg)CPP获得的反应。另一方面,我们的结果表明,用不同剂量的纳洛酮(0.5、1或2mg/kg,腹腔注射)、SCH 23390而非舒必利进行3天单次重复给药,随后5天不使用药物,可显著降低吗啡(0.5mg/kg)CPP的获得,并且还会诱导位置厌恶。此外,药物注射对CPP测试阶段的运动活动没有影响。得出的结论是,脑室内重复注射吗啡会诱导行为敏化,这可能是由于阿片类和/或多巴胺能机制所致。